Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (131-140 of 230) with videos related to

Pageof 23
Sort By:
European Journal of Dermatology : EJD|October 17, 2018
Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challengeSophie Lalevee, Nicolas Ortonne, Claire Hotz, et al.
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
Calcified Tissue International|February 9, 2021
Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in FranceMaud Jalabert, Salah Ferkal, Jean-Claude Souberbielle, et al.
Human Pathology|January 4, 2011
SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehogAmélie Carbonnelle-Puscian, Valérie Vidal, Ingrid Laurendeau, et al.
Journal of the American Academy of Dermatology|April 28, 2022
Bullous pemphigoid: Three main clusters defining 3 outcome profilesFlorine Guerrois, Elsa Hassan, Thomas Bettuzzi, et al.
Oncotarget|February 4, 2016
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cellsJennifer Varin, Laury Poulain, Mikael Hivelin, et al.
Journal of the American Academy of Dermatology|November 20, 2020
Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020Thomas Bettuzzi, Saskia Ingen-Housz-Oro, Carmen Chinchilla Purtillo, et al.
The Journal of Dermatology|December 29, 2022
Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planusAudrey Melin, Sarah Bouchereau, Robin Guelimi, et al.
Brain : a Journal of Neurology|August 4, 2004
Neurofibromatosis 1-associated neuropathies: a reappraisalAlain Drouet, Pierre Wolkenstein, Jean-Pascal Lefaucheur, et al.
Human Molecular Genetics|May 7, 2009
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Audrey Sabbagh, Eric Pasmant, Ingrid Laurendeau, et al.
Pageof 23

Showing results (131-140 of 230) with videos related to

Sort By:
Pageof 23
European Journal of Dermatology : EJD|October 17, 2018
Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challengeSophie Lalevee, Nicolas Ortonne, Claire Hotz, et al.
Brain : a Journal of Neurology|December 13, 2002
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patientsJean-Sébastien Guillamo, Alain Créange, Chantal Kalifa, et al.
Calcified Tissue International|February 9, 2021
Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in FranceMaud Jalabert, Salah Ferkal, Jean-Claude Souberbielle, et al.
Human Pathology|January 4, 2011
SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehogAmélie Carbonnelle-Puscian, Valérie Vidal, Ingrid Laurendeau, et al.
Journal of the American Academy of Dermatology|April 28, 2022
Bullous pemphigoid: Three main clusters defining 3 outcome profilesFlorine Guerrois, Elsa Hassan, Thomas Bettuzzi, et al.
Oncotarget|February 4, 2016
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cellsJennifer Varin, Laury Poulain, Mikael Hivelin, et al.
Journal of the American Academy of Dermatology|November 20, 2020
Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020Thomas Bettuzzi, Saskia Ingen-Housz-Oro, Carmen Chinchilla Purtillo, et al.
The Journal of Dermatology|December 29, 2022
Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planusAudrey Melin, Sarah Bouchereau, Robin Guelimi, et al.
Brain : a Journal of Neurology|August 4, 2004
Neurofibromatosis 1-associated neuropathies: a reappraisalAlain Drouet, Pierre Wolkenstein, Jean-Pascal Lefaucheur, et al.
Human Molecular Genetics|May 7, 2009
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1Audrey Sabbagh, Eric Pasmant, Ingrid Laurendeau, et al.
Pageof 23